Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL

131 views
May 13, 2024

Chapters

Highlighting Phase II BOVen Trial for TP53 Mutant MCL

00:00

Exploring SYMPATICO & BRUIN Trials in Relapsed MCL

03:24

Assessing Bispecific Antibodies for Aggressive B-cell Lymphomas

07:06

Analyzing Treatment Intensity & Loncastuximab Effectiveness in DLBCL

11:37

Unveiling Mosunetuzumab & Bispecific Approaches in Follicular Lymphoma

14:33

Delving Into FLAIR Trial & Sonrotoclax Combo for Treatment-Naive CLL

19:32

Comparing Zanubrutinib vs. Ibrutinib in ALPINE Study for R/R CLL

22:21

Summarizing MCL Updates: Promising Therapies & Treatment Strategies

24:05

Reviewing BTK/BCL2 Combinations & Bispecific Benefits for Lymphomas

25:25

Comments 0
Login to view comments. Click here to Login